propranolol has been researched along with maytansine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hansch, C; Khwaja, TA; Selassie, CD | 1 |
| Bregeon, B; Dréno, B; Frénard, C; Khammari, A; Peuvrel, L; Quéreux, G; Saint-Jean, M; Wdowik, A | 1 |
2 other study(ies) available for propranolol and maytansine
| Article | Year |
|---|---|
Structure-activity relationships of antineoplastic agents in multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
First case of trastuzumab emtansine-associated hemorrhagic telangiectasias treated with propranolol.
Topics: Ado-Trastuzumab Emtansine; Adrenergic beta-Antagonists; Antineoplastic Agents, Immunological; Female; Hemostatic Disorders; Humans; Maytansine; Middle Aged; Propranolol; Skin; Telangiectasis; Trastuzumab; Treatment Outcome | 2019 |